Altered molecular adaptation to exercise in children with type 1 diabetes: beyond hypoglycemia
Jaime S Rosa,
Pietro R Galassetti,
Jaime S Rosa
Department of Pediatrics, Institute for Clinical Translational Science, University of California, Irvine, Orange, CA, USA
Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA, USA
Search for more papers by this authorCorresponding Author
Pietro R Galassetti
Department of Pediatrics, Institute for Clinical Translational Science, University of California, Irvine, Orange, CA, USA
Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA, USA
Pietro Galassetti, MD, PhDDepartment of PediatricsInstitute for Clinical Translational ScienceUniversity of California, Irvine2nd Floor, Building 25101 The City DriveOrange, CA 92868USA.Tel: (949) 456-5357;fax: (949) 456-2934;e-mail: [email protected]Search for more papers by this authorJaime S Rosa,
Pietro R Galassetti,
Jaime S Rosa
Department of Pediatrics, Institute for Clinical Translational Science, University of California, Irvine, Orange, CA, USA
Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA, USA
Search for more papers by this authorCorresponding Author
Pietro R Galassetti
Department of Pediatrics, Institute for Clinical Translational Science, University of California, Irvine, Orange, CA, USA
Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA, USA
Pietro Galassetti, MD, PhDDepartment of PediatricsInstitute for Clinical Translational ScienceUniversity of California, Irvine2nd Floor, Building 25101 The City DriveOrange, CA 92868USA.Tel: (949) 456-5357;fax: (949) 456-2934;e-mail: [email protected]Search for more papers by this author
References
- 1 Laaksonen DE, Atalay M, Niskanen LK et al. Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc 2000: 32: 1541–1548.
- 2 Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005: 116: 473–480.
- 3 Berenson GS, Srinivasan SR, Bao W et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998: 338: 1650–1656.
- 4 Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994: 330: 1549–1554.
- 5 Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006: 144: 73–81.
- 6 Strong WB, Malina RM, Blimkie CJ et al. Evidence based physical activity for school-age youth. Pediatrics 2005: 146: 732–737.
- 7 Timmons BW, Tarnopolsky MA, Bar-Or O. Immune responses to strenuous exercise and carbohydrate intake in boys and men. Pediatr Res 2004: 56: 227–234.
- 8 Nemet D, Oh Y, Kim HS, Hill M, Cooper DM. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 2002: 110: 681–689.
- 9 Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003: 189: 41–54.
- 10 Nikolaidis M, Kyparos A, Hadziioannou M et al. Acute exercise markedly increases blood oxidative stress in boys and girls. Appl Physiol Nutr Metab 2007: 32: 197–205.
- 11 Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol Endocrinol Metab 1993: 264: E149–E155.
- 12 Galassetti PR, Iwanaga K, Crisostomo M, Zaldivar FP, Larson J, Pescatello A. Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes 2006: 7: 16–24.
- 13 Connolly PH, Caiozzo VJ, Zaldivar F et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 2004: 97: 1461–1469.
- 14 Nieman DC, Davis JM, Henson DA et al. Muscle cytokine mRNA changes after 2.5 h of cycling: influence of carbohydrate. Med Sci Sports Exerc 2005: 37: 1283–1290.
- 15 Cooper DM, Nemet D, Galassetti P. Exercise, stress, and inflammation in the growing child: from the bench to the playground. Curr Opin Pediatr 2004: 16: 286–292.
- 16 The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977–986.
- 17 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000: 342: 381–389.
- 18 The Diabetes Control and Complications Trial (DCCT)/The Epidemiology of Diabetes Interventions and Complications (EDIC) Research Groups. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). Pediatrics 2001: 139: 804–812.
- 19 The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002: 287: 2563–2569.
- 20 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005: 353: 2643–2653.
- 21 Hambrecht R, Wolf A, Gielen S et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000: 342: 454–460.
- 22 Pedersen O, Beck-Nielsen H, Heding L. Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med 1980: 302: 886–892.
- 23 Smith AG, Muscat GE. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int J Biochem Cell Biol 2005: 37: 2047–2063.
- 24 Teran-Garcia M, Rankinen T, Koza RA, Rao DC, Bouchard C. Endurance training-induced changes in insulin sensitivity and gene expression. Am J Physiol Endocrinol Metab 2005: 288: E1168–E1178.
- 25 Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007: 103: 700–709.
- 26 Cryer PE. Glucose counterregulation in man. Diabetes 1981: 30: 261–264.
- 27 Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003: 26: 1902–1912.
- 28 Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 1997: 273: E1039–E1051.
- 29 Camacho RC, Galassetti P, Davis SN, Wasserman DH. Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev 2005: 33: 17–23.
- 30 Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 2002: 51: S271–S283.
- 31 De Feo P, Perriello G, Torlone E et al. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol Endocrinol Metab 1991: 261: E725–E736.
- 32 De Feo P, Perriello G, Torlone E et al. Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol Endocrinol Metab 1989: 256: E835–E843.
- 33 De Feo P, Perriello G, Torlone E et al. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol Endocrinol Metab 1989: 257: E35–E42.
- 34 Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005: 98: 1154–1162.
- 35 Galassetti PR, Iwanaga K, Pontello AM, Zaldivar FP, Flores RL, Larson JK. Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes. Am J Physiol Endocrinol Metab 2006: 290: E833–E839.
- 36 Petersen KF, Price TB, Bergeron R. Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin Endocrinol Metab 2004: 89: 4656–4664.
- 37 The Diabetes Research in Children Network Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006: 29: 20–25.
- 38 Wanke T, Auinger M, Formanek D et al. Defective endogenous opioid response to exercise in type I diabetic patients. Metabolism 1996: 45: 137–142.
- 39
Bjorgaas M,
Vik T,
Sand T et al. Counterregulatory hormone and symptom responses to hypoglycaemia in diabetic children.
Diabet Med
1997: 14: 433–441.
10.1002/(SICI)1096-9136(199706)14:6<433::AID-DIA350>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- 40 Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care 1991: 14: 81–88.
- 41 Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973: 182: 171–173.
- 42 Ross LA, Warren RE, Kelnar CJ, Frier BM. Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes. Arch Dis Child 2005: 90: 190–194.
- 43 Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002: 51: 958–965.
- 44 McCrimmon RJ, Evans ML, Jacob RJ et al. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. Am J Physiol Endocrinol Metab 2002: 283: E1076–E1083.
- 45 Karavanaki K. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2003: 16: 79–90.
- 46 Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN. Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes 2003: 52: 1761–1769.
- 47 Davis SN, Galassetti P, Wasserman DH, Tate D. Effects of antecedent hypoglycemia on subsequent counterregulatory responses to exercise. Diabetes 2000: 49: 73–81.
- 48 Galassetti P, Tate D, Neill RA, Richardson A, Leu SY, Davis SN. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab 2006: 290: E1109–E1117.
- 49 Galassetti P, Mann S, Tate D, Neill RA, Wasserman DH, Davis SN. Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise. J Appl Physiol 2001: 91: 91–99.
- 50 Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. Diabetes 2004: 53: 1798–1806.
- 51 The Diabetes Research in Children Network Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. Pediatrics 2005: 147: 528–534.
- 52 Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med 2000: 21: 1–12.
- 53 Jones TW, Porter P, Sherwin RS et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998: 338: 1657–1662.
- 54 The Diabetes Research in Children Network Study Group. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes 2007: 8: 199–205.
- 55 Kaufman FR, Austin J, Neinstein A et al. Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes. J Pediatr 2002: 141: 625–630.
- 56 McMahon SK, Ferreira LD, Ratnam N et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 2007: 92: 963–968.
- 57 Robertson K, Adolfsson P, Riddell MC, Scheiner G, Hanas R. Exercise in children and adolescents with diabetes. Pediatr Diabetes 2008: 9: 65–77.
- 58 Lassarre C, Girard F, Durand J, Raynaud J. Kinetics of human growth hormone during submaximal exercise. J Appl Physiol 1974: 37: 826–830.
- 59 Stokes KA, Nevill ME, Hall GM, Lakomy HK. Growth hormone responses to repeated maximal cycle ergometer exercise at different pedaling rates. J Appl Physiol 2002: 92: 602–608.
- 60 Mejri S, Bchir F, Rayana MC, Hamida J, Slama C. Effect of training on GH and IGF-1 responses to a submaximal exercise in football players. Eur J Appl Physiol 2005: 95: 496–503.
- 61 Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001: 86: 4753–4758.
- 62 Patel YC, Srikant CB. Somatostatin mediation of adenohypophysial secretion. Annu Rev Physiol 1986: 48: 551–567.
- 63 Dall R, Kanaley J, Hansen TK et al. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol 2002: 147: 65–70.
- 64 Maas HCM, DeVries WR, Maitimu I, Bol E, Bowers CY, Koppeschaar HPF. Growth hormone responses during strenuous exercise: the role of GH-releasing hormone and GH-releasing peptide-2. Med Sci Sports Exerc 2000: 32: 1226–1232.
- 65 Di Luigi L, Conti FG, Casini A et al. Growth hormone and insulin-like growth factor I responses to moderate submaximal acute physical exercise in man: effects of octreotide, a somatostatin analogue, administration. Int J Sports Med 1997: 18: 257–263.
- 66 Kozłowski S, Chwalbińska-Moneta J, Vigš M, Kaciuba-Uściłko H, Nazar K. Greater serum GH response to arm than to leg exercise performed at equivalent oxygen uptake. Eur J Appl Physiol 1983: 52: 131–135.
- 67 Vanhelder WP, Goode RC, Radomski MW. Effect of anaerobic and aerobic exercise of equal duration and work expenditure on plasma growth hormone levels. Eur J Appl Physiol 1984: 52: 255–257.
- 68 VanHelder W, Casey K, Radomski M. Regulation of growth hormone during exercise by oxygen demand and availability. Eur J Appl Physiol 1987: 56: 628–632.
- 69 Viru M, Jansson E, Viru A, Sundberg CJ. Effect of restricted blood flow on exercise-induced hormone changes in healthy men. Eur J Appl Physiol 1998: 77: 517–522.
- 70 Kjaer M, Hanel B, Worm L et al. Cardiovascular and neuroendocrine responses to exercise in hypoxia during impaired neural feedback from muscle. Am J Physiol Regul Integr Comp Physiol 1999: 277: R76–R85.
- 71 Weltman A, Pritzlaff CJ, Wideman L et al. Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow. J Appl Physiol 2000: 89: 629–635.
- 72 Kjaer M, Secher NH, Bach FW, Galbo H. Role of motor center activity for hormonal changes and substrate mobilization in humans. Am J Physiol Regul Integr Comp Physiol 1987: 253: R687–R695.
- 73 McCall GE, Grindeland RE, Roy RR, Edgerton VR. Muscle afferent activity modulates bioassayable growth hormone in human plasma. J Appl Physiol 2000: 89: 1137–1141.
- 74 Christensen SE, Jørgensen OL, Møller N, Orskov H. Characterization of growth hormone release in response to external heating. Comparison to exercise induced release. Acta Endocrinol (Copenh) 1984: 107: 295–301.
- 75 Galassetti P, Larson J, Iwanaga K, Salsberg SL, Eliakim A, Pontello A. Effect of a high-fat meal on the growth hormone response to exercise in children. J Pediatr Endocrinol Metab 2006: 19: 777–786.
- 76 Eliakim A, Nemet D, Zaldivar F et al. Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents. J Appl Physiol 2006: 100: 1630–1637.
- 77 Hoos MB, Kuipers H, Gerver W-J, Westerterp KR. Physical activity pattern of children assessed by triaxial accelerometry. Eur J Clin Nutr 2004: 58: 1425–1428.
- 78 Dunger D, Acerini C. IGF-I and diabetes in adolescence. Diabetes Metab 1998: 24: 101–107.
- 79 Ji S, Guan R, Frank SJ, Messina JL. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 1999: 274: 13434–13442.
- 80 Danne T, Kordonouri O, Enders I, Weber B. Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997: 20: 281–285.
- 81 Holl RW, Grabert M, Heinze E, Sorgo W, Debatin KM. Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus. Eur J Pediatr 1998: 157: 972–977.
- 82 Backeljauw PF, Underwood LE. Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. J Clin Endocrinol Metab 2001: 86: 1504–1510.
- 83 Veldhuis JD, Roemmich JN, Richmond EJ et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005: 26: 114–146.
- 84 Ohlsson C, Bengtsson B-A, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev 1998: 19: 55–79.
- 85 Musaro A, McCullagh K, Paul A et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001: 27: 195–200.
- 86 Kim H, Barton E, Muja N, Yakar S, Pennisi P, LeRoith D. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 2005: 146: 1772–1779.
- 87 Kilgour E, Gout I, Anderson NG. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways. Biochem J 1996: 315: 517–522.
- 88 Argetsinger LS, Hsu GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 1995: 270: 14685–14692.
- 89 Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 1996: 271: 29415–29421.
- 90 Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 1998: 273: 1285–1287.
- 91 Pierce AL, Fukada H, Dickhoff WW. Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes. J Endocrinol 2005: 184: 341–349.
- 92 Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995: 16: 3–34.
- 93 Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999: 20: 761–787.
- 94 Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004: 151: U109–U117.
- 95 Iida K, Rosen CJ, Ackert-Bicknell C, Thorner MO. Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels. J Endocrinol 2005: 186: 481–489.
- 96 Baxter RC, Turtle JR. Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun 1978: 84: 350–357.
- 97 Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 1980: 107: 1176–1181.
- 98 Bereket A, Lang CH, Blethen SL et al. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995: 80: 1312–1317.
- 99 Moran A, Jacobs DR Jr, Steinberger J et al. Association between the insulin resistance of puberty and the insulin-like growth factor-I growth hormone axis. J Clin Endocrinol Metab 2002: 87: 4817–4820.
- 100 McCusker RH. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. J Dairy Sci 1998: 81: 1790–1800.
- 101 Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994: 79: 872–878.
- 102 Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP. Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990: 71: 1356–1362.
- 103 Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991: 73: 964–968.
- 104 Holly J, Dunger D, Edge J, Smith C, Chard T, Wass J. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabet Med 1990: 7: 618–623.
- 105 Brown M, Ahmed M, Clayton K, Dunger D. Growth during childhood and final height in type 1 diabetes. Diabet Med 1994: 11: 182–187.
- 106 Hellstrom A, Carlsson B, Niklasson A et al. IGF-I is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 2002: 87: 3413–3416.
- 107 Amin R, Schultz C, Ong K et al. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford regional prospective study. Diabetes Care 2003: 26: 1456–1461.
- 108 Janssen JA, Jacobs ML, Derkx FH, Weber RF, Van DerLely AJ, Lamberts SW. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 2809–2815.
- 109 Hellstrom A, Perruzzi C, Ju M et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 2001: 98: 5804–5808.
- 110 Modanlou HD, Gharraee Z, Hasan J, Waltzman J, Nageotte S, Beharry KD. Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest Ophthalmol Vis Sci 2006: 47: 738–744.
- 111 Kraemer RR, Durand RJ, Acevedo EO et al. Rigorous running increases growth hormone and insulin-like growth factor-I without altering ghrelin. Exp Biol Med 2004: 229: 240–246.
- 112 Eliakim A, Scheett TP, Newcomb R, Mohan S, Cooper DM. Fitness, training, and the growth hormone->insulin-like growth factor I axis in prepubertal girls. J Clin Endocrinol Metab 2001: 86: 2797–2802.
- 113 Cappon J, Brasel JA, Mohan S, Cooper DM. Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol 1994: 76: 2490–2496.
- 114 Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM. Physical fitness, endurance training, and the growth hormone-insulin- like growth factor I system in adolescent females. J Clin Endocrinol Metab 1996: 81: 3986–3992.
- 115 Eliakim A, Brasel JA, Mohan S, Wong WLT, Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol Regul Integr Comp Physiol 1998: 275: R308–R314.
- 116 Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996: 81: 3492–3497.
- 117 Eliakim A, Moromisato M, Moromisato D, Brasel JA, Roberts C Jr, Cooper DM. Increase in muscle IGF-I protein but not IGF-I mRNA after 5 days of endurance training in young rats. Am J Physiol Regul Integr Comp Physiol 1997: 273: R1557–R1561.
- 118 Admon G, Weinstein Y, Falk B et al. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics 2005: 116: e348–e355.
- 119 Stokes K, Nevill M, Frystyk J, Lakomy H, Hall G. Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts. J Appl Physiol 2005: 99: 1254–1261.
- 120 Kanaley JA, Weltman JY, Veldhuis JD, Rogol AD, Hartman ML, Weltman A. Human growth hormone response to repeated bouts of aerobic exercise. J Appl Physiol 1997: 83: 1756–1761.
- 121 Ronsen O, Haug E, Pedersen BK, Bahr R. Increased neuroendocrine response to a repeated bout of endurance exercise. Med Sci Sports Exerc 2001: 33: 568–575.
- 122 Goto K, Higashiyama M, Ishii N, Takamatsu K. Prior endurance exercise attenuates growth hormone response to subsequent resistance exercise. Eur J Appl Physiol 2005: 94: 333–338.
- 123 Goto K, Ishii N, Mizuno A, Takamatsu K. Enhancement of fat metabolism by repeated bouts of moderate endurance exercise. J Appl Physiol 2007: 102: 2158–2164.
- 124 Scheett TP, Nemet D, Stoppani J, Maresh CM, Newcomb R, Cooper DM. The effect of endurance-type exercise training on growth mediators and inflammatory cytokines in pre-pubertal and early pubertal males. Pediatr Res 2002: 52: 491–497.
- 125 Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med 1999: 222: 283–292.
- 126 Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001: 414: 813–820.
- 127 Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005: 352: 1685–1695.
- 128 Johansen J, Harris A, Rychly D, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005: 4: 5.
- 129 Finaud J, Lac G, Filaire E. Oxidative stress: relationship with exercise and training. Sports Med 2006: 36: 327–358.
- 130 Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005: 45: 1563–1569.
- 131 Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med 2000: 21: 21–24.
- 132 Leeuwenburgh C, Fiebig R, Chandwaney R, Ji LL. Aging and exercise training in skeletal muscle: responses of glutathione and antioxidant enzyme systems. Am J Physiol Regul Integr Comp Physiol 1994: 267: R439–R445.
- 133 Leeuwenburgh C, Hollander J, Leichtweis S, Griffiths M, Gore M, Ji LL. Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol Regul Integr Comp Physiol 1997: 272: R363–R369.
- 134 Pialoux V, Mounier R, Ponsot E et al. Effects of exercise and training in hypoxia on antioxidant/pro-oxidant balance. Eur J Clin Nutr 2006: 60: 1345–1354.
- 135 Oberbach A, Tonjes A, Kloting N et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006: 154: 577–585.
- 136 Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M. Exercise reduces resistin and inflammatory cytokines in patients with type 2 diabetes. Diabetes Care 2007: 30: 719–721.
- 137 Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967: 242: 2278–2282.
- 138 Timmons BW, Tarnopolsky MA, Snider DP, Bar-Or O. Immunological changes in response to exercise: influence of age, puberty, and gender. Med Sci Sports Exerc 2006: 38: 293–304.
- 139 Rosa JS, Oliver SR, Flores RL et al. Kinetic profiles of 18 systemic pro- and anti-inflammatory mediators during and following exercise in children. J Pediatr Endocrinol Metab 2006: 20: 1293–1305.
- 140 Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998: 55: 1139–1149.
- 141 Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR. Sustained IL-1α, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008: 9: 9–16.
- 142 Rosa JS, Oliver SR, Mitsuhashi M et al. Altered kinetics of IL-6 and other inflammatory mediators during exercise in children with type 1 diabetes. J Investig Med 2008: 56: 701–713.
- 143 Mylona-Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. Pediatr Diabetes 2006: 7: 51–59.
- 144 Powers SK, Criswell D, Lawler J et al. Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol 1994: 266: R375–R380.
- 145 Villa-Caballero L, Nava-Ocampo AA, Frati-Munari A, Ponce-Monter H. Oxidative stress, acute and regular exercise: are they really harmful in the diabetic patient? Med Hypotheses 2000: 55: 43–46.
- 146 Fenster CP, Weinsier RL, Darley-Usmar VM, Patel RP. Obesity, aerobic exercise, and vascular disease: the role of oxidant stress. Obes Res 2002: 10: 964–968.
- 147 Davison GW, George L, Jackson SK et al. Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radic Biol Med 2002: 33: 1543–1551.
- 148 Simsek M, Naziroglu M, Erdinc A. Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats. Exp Clin Endocrinol Diabetes 2005: 113: 53–59.
- 149 Armon Y, Cooper DM, Flores R, Zanconato S, Barstow TJ. Oxygen uptake dynamics during high-intensity exercise in children and adults. J Appl Physiol 1991: 70: 841–848.
- 150 Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004: 53: 2079–2086.
- 151 Ostrowski K, Hermann C, Bangash A, Schjerling P, Nielsen JN, Pedersen BK. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 1998: 513: 889–894.
- 152 Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002: 136: 493–503.
- 153 Carnethon MR, Gidding SS, Nehgme R, Sidney S, Jacobs DR Jr, Liu K. Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA 2003: 290: 3092–3100.
- 154 American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006: 29: S4–S42.
- 155 Fan J, Wojnar MM, Theodorakis M, Lang CH. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol Regul Integr Comp Physiol 1996: 270: R621–R629.
- 156 Ahmad I, Zaldivar F, Iwanaga K et al. Inflammatory and growth mediators in growing preterm infants. J Pediatr Endocrinol Metab 2007: 20: 387–396.
- 157 De Benedetti F, Alonzi T, Moretta A et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997: 99: 643–650.
- 158 Neufer PD, Dohm GL. Exercise induces a transient increase in transcription of the GLUT-4 gene in skeletal muscle. Am J Physiol Cell Physiol 1993: 265: C1597–C1603.
- 159 Kraniou Y, Cameron-Smith D, Misso M, Collier G, Hargreaves M. Effects of exercise on GLUT-4 and glycogenin gene expression in human skeletal muscle. J Appl Physiol 2000: 88: 794–796.
- 160 McGee SL, Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes 2004: 53: 1208–1214.
- 161 McGee SL, Sparling D, Olson AL, Hargreaves M. Exercise increases MEF2- and GEF DNA-binding activities in human skeletal muscle. FASEB J 2005: 20: 348–349.
- 162 Holmes B, Dohm GL. Regulation of GLUT4 gene expression during exercise. Med Sci Sports Exerc 2004: 36: 1202–1206.
- 163 McCarty MF. Up-regulation of PPAR-gamma coactivator-1alpha as a strategy for preventing and reversing insulin resistance and obesity. Med Hypotheses 2005: 64: 399–407.
- 164 Li X, Hansen PA, Xi L, Chandraratna RAS, Burant CF. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor-gamma and retinoic acid X receptors. J Biol Chem 2005: 280: 38317–38327.
- 165 Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 1996: 45: 23–27.
- 166 Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT. Increase of anti-oxidation by exercise in the liver of obese Zucker rats. Clin Exp Pharmacol Physiol 2004: 31: 506–511.
- 167 Colombo M, Gregersen S, Kruhoeffer M et al. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis. Metabolism 2005: 54: 1571–1581.
- 168 Fedele MJ, Hernandez JM, Lang CH et al. Severe diabetes prohibits elevations in muscle protein synthesis after acute resistance exercise in rats. J Appl Physiol 2000: 88: 102–108.
- 169 Akerstrom T, Steensberg A, Keller P, Keller C, Penkowa M, Pedersen BK. Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 2005: 563: 507–516.
- 170 Chan MH, Carey AL, Watt MJ, Febbraio MA. Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr Comp Physiol 2004: 287: R322–R327.
- 171 Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 2004: 18: 992–994.
- 172 Tomiya A, Aizawa T, Nagatomi R, Sensui H, Kokubun S. Myofibers express IL-6 after eccentric exercise. Am J Sports Med 2004: 32: 503–508.
- 173 Penkowa M, Keller C, Keller P, Jauffred S, Pedersen BK. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 2003: 17: 2166–2168.
- 174 Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002: 283: E1272–E1278.
- 175 Keller C, Keller P, Marshal S, Pedersen BK. IL-6 gene expression in human adipose tissue in response to exercise - effect of carbohydrate ingestion. J Physiol 2003: 550: 927–931.
- 176 Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J 2005: 19: 1498–1500.
